{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:43:31Z","timestamp":1756464211865},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[1997]]},"DOI":"10.1080\/00313029700169205","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T18:29:00Z","timestamp":1128623340000},"page":"320-323","source":"Crossref","is-referenced-by-count":15,"title":["Two case reports of breast carcinoma associated with prolactinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Inara","family":"Strungs","sequence":"first","affiliation":[]},{"given":"Robert A.G.","family":"Gray","sequence":"additional","affiliation":[]},{"given":"Hugh B.","family":"Rigby","sequence":"additional","affiliation":[]},{"given":"Geoffrey","family":"Strutton","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1080\/00313029700169205_bib0005","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1530\/acta.0.0820746","article-title":"Breast cancer in the Forbes-Albright syndrome","volume":"82","author":"Daniels","year":"1976","journal-title":"Acta endocrinol"},{"key":"10.1080\/00313029700169205_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0028-2243(81)90035-6","article-title":"Amenorrhea, galactorrhea, hyperprolactinaemia syndrome and breast carcinoma in a young woman","volume":"11","author":"Buytaert","year":"1985","journal-title":"Eur J Gynaecol Reprod Biol"},{"key":"10.1080\/00313029700169205_bib0015","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/1097-0142(19840501)53:9<1974::AID-CNCR2820530928>3.0.CO;2-G","article-title":"Hypophyseal tumour and gynecomastia preceding bilateral breast cancer development in a man","volume":"53","author":"Olsson","year":"1984","journal-title":"Cancer"},{"key":"10.1080\/00313029700169205_bib0020","first-page":"367","article-title":"Breast cancer in a patient with prolactinoma","volume":"98","author":"Theodorakis","year":"1985","journal-title":"Surgery"},{"key":"10.1080\/00313029700169205_bib0025","first-page":"251","article-title":"Breast Cancer in a Male Patient with Prolactinoma","volume":"23","author":"Haga","year":"1993","journal-title":"Jpn J Surg"},{"key":"10.1080\/00313029700169205_bib0030","series-title":"Endocrinology","first-page":"384","article-title":"Prolactin: Normal Synthesis, Regulation, and Actions","author":"Cooke","year":"1989"},{"key":"10.1080\/00313029700169205_bib0035","first-page":"963","article-title":"Prolactin and murine mammary tumorigenesis: a review","volume":"37","author":"Welsch","year":"1979","journal-title":"Cancer Res"},{"key":"10.1080\/00313029700169205_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2964(79)90037-9","article-title":"Prolactin and Human Breast Cancer: A Review","volume":"15","author":"Nagasawa","year":"1979","journal-title":"Eur J Cancer"},{"key":"10.1080\/00313029700169205_bib0045","first-page":"601","article-title":"Prolactin and the induction of mammary tumors in mice","volume":"2","author":"Boot","year":"1962","journal-title":"Gen Comp Endocrinol"},{"key":"10.1080\/00313029700169205_bib0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3181\/00379727-138-36036","article-title":"Regression of spontaneous mammary tumors in rats by ergot drugs","volume":"138","author":"Quadri","year":"1971","journal-title":"Pros Soc Exp Biol Med"},{"key":"10.1080\/00313029700169205_bib0055","first-page":"715","article-title":"Inhibition of mammary- tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomised mice","volume":"48","author":"Yanai","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1080\/00313029700169205_bib0060","first-page":"4102","article-title":"Prolactin levels in populations at risk for breast cancer","volume":"36","author":"Hill","year":"1976","journal-title":"Cancer Res"},{"key":"10.1080\/00313029700169205_bib0065","series-title":"Hormones and Breast Cancer","first-page":"115","article-title":"Prolactin\u2014an important hormone in breast neoplasia?","author":"Henderson","year":"1981"},{"key":"10.1080\/00313029700169205_bib0070","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/1097-0142(197405)33:5<1325::AID-CNCR2820330517>3.0.CO;2-V","article-title":"Plasma prolactin and breast cancer","volume":"33","author":"Wilson","year":"1979","journal-title":"Cancer"},{"issue":"16","key":"10.1080\/00313029700169205_bib0075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM197510162931602","article-title":"Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer","volume":"293","author":"Henderson","year":"1975","journal-title":"New Eng J Med"},{"key":"10.1080\/00313029700169205_bib0080","first-page":"441","article-title":"Plasma prolactin and its relationship to risk factors in human breast cancer","volume":"17","author":"Kwa","year":"1976","journal-title":"In J Cancer"},{"key":"10.1080\/00313029700169205_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijc.2910200104","article-title":"An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer","volume":"20","author":"Kwa","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1080\/00313029700169205_bib0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/jcem-53-1-179","article-title":"Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression","volume":"53","author":"Levin","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1080\/00313029700169205_bib0095","first-page":"4006","article-title":"Plasma hormone profiles of young women at risk for familial breast cancer","volume":"38","author":"Fishman","year":"1978","journal-title":"Cancer Res"},{"key":"10.1080\/00313029700169205_bib0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.1973.74","article-title":"Determination of in vitro hormone dependence of human breast cancer","volume":"28","author":"Flax","year":"1973","journal-title":"Brit J Cancer"},{"key":"10.1080\/00313029700169205_bib0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/bjc.1975.66","article-title":"An assessment of the effects of hormones on short term organ cultures of human breast carcinomata,","volume":"31","author":"Beeby","year":"1975","journal-title":"Br J Cancer"},{"key":"10.1080\/00313029700169205_bib0110","first-page":"305","article-title":"Prospective Randomised Trial Concerning Hyper- and Normoprolactinemia and the Use of BromoergocD\u2019ptine in Patients with Metastatic Breast Cancer","volume":"9","author":"Fritze","year":"1986","journal-title":"Onkologie"},{"key":"10.1080\/00313029700169205_bib0115","first-page":"86","article-title":"Pathophysiologie der Hyperprolaktingmie beim Mammakarzinom","volume":"11","author":"Hottkamp","year":"1988","journal-title":"Onkologie"},{"key":"10.1080\/00313029700169205_bib0120","first-page":"409","article-title":"Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of C erb B-2 oncoprotein","volume":"19","author":"Bhatavdekar","year":"1993","journal-title":"Eur J Surg Onc"},{"key":"10.1080\/00313029700169205_bib0125","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1097-0142(19811215)48:12<2687::AID-CNCR2820481221>3.0.CO;2-A","article-title":"Plasma Prolactin Levels in Patients with Breast Cancer","volume":"48","author":"Rose","year":"1981","journal-title":"Cancer"},{"key":"10.1080\/00313029700169205_bib0130","first-page":"17","article-title":"Prolactin receptors in human breast tumours","volume":"73","author":"Morgan","year":"1977","journal-title":"J Endocrinol"},{"key":"10.1080\/00313029700169205_bib0135","first-page":"18","article-title":"Prolactin: Hyperprolactinaemic Syndromes and Management","volume":"408","author":"Vance","year":"1989"},{"key":"10.1080\/00313029700169205_bib0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","article-title":"Reproductive factors and breast cancer","volume":"15","author":"Kelsey","year":"1993","journal-title":"Epidemiol Rev"},{"issue":"2","key":"10.1080\/00313029700169205_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199401133300201","article-title":"Lactation and a reduced risk of premenopausal breast cancer","volume":"330","author":"Newcomb","year":"1994","journal-title":"N Engl J Med"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251635036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251635036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T08:23:39Z","timestamp":1553847819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251635036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997]]}},"alternative-id":["S003130251635036X"],"URL":"https:\/\/doi.org\/10.1080\/00313029700169205","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[1997]]}}}